Clinical trial Recruiting at 1 site Interventional Ages 50 to 80

Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

Official title: ALIA Kuwait: A Prospective Pilot Feasibility Study of Low-Dose Computed Tomography Screening for Lung Cancer in High-Risk Individuals in Kuwait

Run by Chest Diseases Hospital, Ministry of Health, Kuwait · NCT07766538 · Data updated 2026-11-12

This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

More Lung Cancer trials

Quick facts

Study typeInterventional
Ages50 Years to 80 Years
SexAll
Enrollment590 (estimated)
SponsorChest Diseases Hospital, Ministry of Health, Kuwait
Government
Locations1 site (Kuwait City)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedNovember 30, 2027
Study endsAugust 31, 2029
Registry record updatedNovember 3, 2026
Trial IDNCT07766538 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 50-80 years old with at least 20 pack-years of smoking (including all tobacco forms) and who can provide informed consent.

Probably not a fit

Individuals outside the age range, with lower smoking exposure, or with exclusion criteria such as active cancer surveillance or inability to lie flat for CT may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, interventional feasibility study evaluates uptake and barriers to implementing low-dose CT screening for lung cancer in Kuwait. Eligible participants are adults aged 50-80 with at least 20 pack-years of smoking history, accounting for all tobacco products including shisha. Participants receive a baseline LDCT scan and may undergo two additional annual scans, with screening performed at the Chest Diseases Hospital and recruitment through MOH clinics. The primary goal is to establish a framework for a national screening program, while the co-primary analyses consider the baseline uptake and retention through 12 months. An extension cohort may enroll after the initial cohort closes, contributing to scan-based analyses but not to co-primary outcomes.

Why it matters

Potential benefit: If successful, the study could inform scalable LDCT screening implementation to reduce late-stage lung cancer by identifying high-risk individuals who benefit from early detection.

How similar studies have gone: Prior LDCT screening programs in other settings have shown feasibility and uptake benefits, though this Kuwait-specific feasibility study is among the first in the region.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 50 to 80 years
* Smoking history of at least 20 pack-years, totalled across all smoked tobacco products (cigarettes, shisha/waterpipe, cigars, pipe and roll-your-own tobacco) using pre-specified equivalency conventions (1 shisha head-year = 1 pack-year; 1 cigar = 4 cigarettes; 1 pipe bowl = 2.5 cigarettes; roll-your-own tobacco 1 g = 1 cigarette). Electronic cigarettes, heated tobacco and smokeless products do not count. Current and former smokers are eligible regardless of time since quitting.
* Able to provide informed consent

Exclusion Criteria:

* Previous diagnosis of lung cancer or any other cancer
* Currently under surveillance for pulmonary nodules
* A major comorbidity under active management (for example end-stage heart, lung or liver disease); people whose condition is under routine follow-up, such as COPD on inhaled treatment, bronchiectasis or interstitial lung disease, remain eligible
* Unable to lie flat with arms raised above the head for CT scanning
* Symptoms suggestive of lung cancer (persistent or worsening cough, haemoptysis, or unexplained weight loss of more than 15 lb (about 7 kg) in the past 3-12 months); symptomatic people are referred the same day on the normal diagnostic pathway
* Chest CT for any reason in the past 12 months
* Non-Kuwaiti residents who have lived in Kuwait for less than 2 years

Where it's running

  • Lung Cancer Screening Clinic, Chest Diseases Hospital
    Kuwait City, Kuwait
    Recruiting

Study contacts

  • Principal investigator: Sulaiman Khadadah, MD — Chest Diseases Hospital, Ministry of Health, Kuwait
  • Study coordinator: Sulaiman Khadadah, MD
  • Email: khadadas@tcd.ie
  • Phone: +96555966111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.